Oncology company focused on the clinical development of novel therapies for cancer
- Year invested 2018
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Associated Team
- Website meipharma.com/
- Company Status IPO/Public (NASDAQ: MEIP)
Oncology company focused on the clinical development of novel therapies for cancer